# Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/prices-and-clinical-benefit-of-national-price-negotiated-anticancer-medicines-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yichen Zhang,Yuxuan Wei,Huangqianyu Li,Yixuan Chen,Yiran Guo,Sheng Han,Luwen Shi,Xiaodong Guan |
| Citations | 42 |
| DOI | 10.1007/s40273-022-01161-7 |
| Fields | Economics, Econometrics and Finance |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s40273-022-01161-7.pdf |
| OpenAlex ID | https://openalex.org/W4283691587 |
| PMID | 35764914 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Sheng Han](https://scholariq.org/researchers/sheng-han/)

## Paper journal

- [PharmacoEconomics](https://scholariq.org/journals/pharmacoeconomics/)

## Paper primary topic

- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)

## Paper topics

- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.